Vanda Pharmaceuticals
VNDA
#8249
Rank
HK$2.48 B
Marketcap
HK$41.32
Share price
1.74%
Change (1 day)
12.01%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -HK$1.26 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are HK$0.21 Billion. In 2025 the company made an earning of -HK$1.19 Billion a decrease over its 2024 earnings that were of -HK$0.32 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$1.26 Billion5.74%
2025 -HK$1.19 Billion271.79%
2024 -HK$0.32 Billion191.43%
2023 -HK$0.11 Billion-320.45%
2022 HK$49.62 M-84.99%
2021 HK$0.33 B54.8%
2020 HK$0.21 B19.42%
2019 HK$0.17 B4.93%
2018 HK$0.17 B-228.6%
2017 -HK$0.14 Billion-8.98%
2016 -HK$0.15 Billion-53.79%
2015 -HK$0.32 Billion-30.18%
2014 -HK$0.46 Billion173.08%
2013 -HK$0.17 Billion-25.33%
2012 -HK$0.23 Billion163.61%
2011 -HK$83.96 Million-221.15%
2010 HK$69.29 M-124.53%
2009 -HK$0.29 Billion-29.44%
2008 -HK$0.41 Billion-36.2%
2007 -HK$0.63 Billion21.81%
2006 -HK$0.52 Billion170.55%
2005 -HK$0.2 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.70 B-16,300.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$123.76 B-9,942.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$83.04 B-6,704.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$244.06 B-19,508.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$103.12 B-8,301.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$75.25 B-6,084.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-HK$22 Million-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA